These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23790811)

  • 21. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
    Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
    CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
    Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
    Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early relapse (ER) transcranial magnetic stimulation (TMS) in treatment resistant major depression.
    Pridmore S; Erger S; Rybak M; Kelly E; May T
    Brain Stimul; 2018; 11(5):1098-1102. PubMed ID: 29805096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance treatment of transcranial magnetic stimulation (TMS) for treatment-resistant depression patients responding to acute TMS treatment.
    Chang J; Chu Y; Ren Y; Li C; Wang Y; Chu XP
    Int J Physiol Pathophysiol Pharmacol; 2020; 12(5):128-133. PubMed ID: 33224435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS.
    Wilson S; Croarkin PE; Aaronson ST; Carpenter LL; Cochran M; Stultz DJ; Kozel FA
    J Affect Disord; 2022 Jan; 296():79-88. PubMed ID: 34592659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
    Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
    Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One Hundred Courses of Cluster Maintenance Transcranial Magnetic Stimulation (CM TMS)-A Clinical Audit Study.
    Pridmore S; O'Reilly J; Naguy A; Morey R; Turnier-Shea Y; Rybak M
    Psychopharmacol Bull; 2022 Oct; 52(4):61-68. PubMed ID: 36339276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical repetitive transcranial magnetic stimulation for veterans with major depressive disorder.
    Kozel FA; Hernandez M; Van Trees K; Phillips S; Hashimie J; Weisman M; Obregon D; Sanchez DL; Catalano G; Schultz SK
    Ann Clin Psychiatry; 2017 Nov; 29(4):242-248. PubMed ID: 29069109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression.
    Kito S; Fujita K; Koga Y
    Neuropsychobiology; 2008; 58(1):29-36. PubMed ID: 18781088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression.
    Aguirre I; Carretero B; Ibarra O; Kuhalainen J; Martínez J; Ferrer A; Salva J; Roca M; Gili M; Montoya P; Garcia-Toro M
    J Affect Disord; 2011 May; 130(3):466-9. PubMed ID: 21093060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repetitive transcranial magnetic stimulation in the treatment of depression.
    Pridmore S; Pridmore W
    Aust J Gen Pract; 2018 Mar; 47(3):122-125. PubMed ID: 29621842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
    Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
    J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute and maintenance efficacy.
    Dell'osso B; Altamura AC
    World J Biol Psychiatry; 2009; 10(4 Pt 2):673-6. PubMed ID: 18956262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcranial magnetic stimulation for major depressive disorder: a pragmatic approach to implementing TMS in a clinical practice.
    Derstine T; Lanocha K; Wahlstrom C; Hutton TM
    Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl):S4-11. PubMed ID: 21180663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial.
    Yip AG; George MS; Tendler A; Roth Y; Zangen A; Carpenter LL
    Brain Stimul; 2017; 10(4):847-849. PubMed ID: 28330592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral vascular endothelial growth factor changes after transcranial magnetic stimulation in treatment-resistant depression.
    Fukuda AM; Hindley LE; Kang JWD; Tirrell E; Tyrka AR; Ayala A; Carpenter LL
    Neuroreport; 2020 Nov; 31(16):1121-1127. PubMed ID: 32956213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.